23-10-2024 |
AH |
|
CLB |
Core Laboratories Inc. |
873.99 |
0.27 |
0.21 |
0.22 |
Core Laboratories Non-GAAP EPS of $0.25 beats by $0.02, revenue of $134.39M beats by $0.35M [10/24/2024 10:20 AM] |
18.88 |
1.80 (10.54%) |
17.50 |
0.42 (2.46%) |
13.82 - 25.13 |
528,553 |
350,000 |
500 |
|
|
24-07-2024 |
AH |
|
CLB |
Core Laboratories Inc. |
1,060 |
0.22 |
0.17 |
0.23 |
Core Laboratories Non-GAAP EPS of $0.22 in-line, revenue of $130.58M misses by $2.26M [7/24/2024 5:16 PM] |
24.48 |
2.46 (11.17%) |
22.02 |
0.0 (0.00%) |
13.82 - 27.94 |
930,183 |
530,000 |
15,809 |
|
|
24-04-2024 |
AH |
|
CLB |
Core Laboratories Inc. |
795.16 |
0.13 |
0.11 |
0.08 |
Core Laboratories Non-GAAP EPS of $0.07 misses by $0.08, revenue of $129.6M beats by $5.14M [4/24/2024 5:43 PM] |
17.05 |
0.52 (3.15%) |
17.00 |
0.47 (2.84%) |
13.82 - 27.94 |
584,033 |
420,000 |
9,523 |
|
|
31-01-2024 |
PM |
|
CLB |
CORE LABS INC |
786.00 |
0.19 |
0.20 |
0.00 |
Core Laboratories beats top-line and bottom-line estimates; initiates Q124 outlook [2/1/2024 12:50 AM] |
15.00 |
-0.77 (-4.88%) |
15.77 |
0.0 (0.00%) |
14.78 - 27.94 |
702,719 |
660,000 |
85,556 |
|
|
01-11-2023 |
AH |
|
CLB |
Core Laboratories Inc. |
1,000.00 |
0.22 |
0.18 |
0.18 |
Core Laboratories Non-GAAP EPS of $0.22 in-line, revenue of $125.34M misses by $4.63M [11/1/2023 5:40 PM] |
21.25 |
0.23 (1.09%) |
21.02 |
0.0 (0.00%) |
17.77 - 27.94 |
382,764 |
300,000 |
12,037 |
|
|
26-07-2023 |
AH |
|
CLB |
Core Laboratories Inc. |
1,150 |
0.23 |
0.15 |
0.12 |
Core Laboratories GAAP EPS of $0.48 beats by $0.27, revenue of $127.9M misses by $4.15M [7/26/2023 5:22 PM] |
24.61 |
-0.19 (-0.77%) |
24.80 |
0.0 (0.00%) |
13.19 - 26.80 |
889,769 |
380,000 |
16,054 |
|
|
26-04-2023 |
AH |
5:15 PM ET (Apr 26) |
CLB |
Core Laboratories N.V. |
1,030 |
0.08 |
0.14 |
0.08 |
Core Laboratories GAAP EPS of $0.05 misses by $0.10, revenue of $128M beats by $2.08M [4/26/2023 5:19 PM] |
22.58 |
1.73 (8.30%) |
20.85 |
0.0 (0.00%) |
13.19 - 31.42 |
446,425 |
330,000 |
22,327 |
|
|
01-02-2023 |
AH |
5:15 PM ET (Feb 1) |
CLB |
Core Laboratories N.V. |
1,150 |
0.23 |
0.13 |
0.20 |
Core Laboratories GAAP EPS of $0.14 misses by $0.06, revenue of $127.58M misses by $2.54M [2/1/2023 5:22 PM] |
25.37 |
-0.42 (-1.63%) |
25.79 |
0.0 (0.00%) |
13.19 - 35.83 |
354,906 |
300,000 |
16,096 |
|
|
26-10-2022 |
AH |
5:15 PM ET (Oct 26) |
CLB |
Core Laboratories N.V. |
900.55 |
0.18 |
0.09 |
0.18 |
Core Laboratories Non-GAAP EPS of $0.18 beats by $0.03, revenue of $125.97M misses by $0.16M [10/26/2022 5:25 PM] |
19.02 |
-1.47 (-7.17%) |
20.77 |
0.28 (1.37%) |
13.19 - 35.83 |
735,069 |
520,000 |
4,312 |
|
|
27-07-2022 |
AH |
5:15 PM ET (Jul 27) |
CLB |
Core Laboratories N.V. |
801.88 |
0.12 |
0.12 |
0.18 |
Core Laboratories Non-GAAP EPS of $0.12 misses by $0.02, revenue of $120.9M misses by $0.45M [7/27/2022 5:19 PM] |
18.53 |
-0.20 (-1.07%) |
18.69 |
-0.04 (-0.21%) |
15.21 - 35.97 |
592,530 |
450,000 |
360 |
|
|
27-04-2022 |
AH |
5:15 PM ET (Apr 27) |
CLB |
Core Laboratories N.V. |
1,270 |
0.08 |
0.06 |
0.15 |
Core Laboratories Non-GAAP EPS of $0.08 beats by $0.02, revenue of $115.3M beats by $3.52M [4/27/2022 5:21 PM] |
26.33 |
-0.52 (-1.94%) |
26.85 |
0.0 (0.00%) |
21.08 - 49.87 |
561,846 |
470,000 |
12,276 |
|
|
02-02-2022 |
AH |
5:15 PM ET (Feb 2) |
CLB |
Core Laboratories N.V. |
1,220 |
0.20 |
0.20 |
0.18 |
Core Laboratories Non-GAAP EPS of $0.20 in-line, revenue of $125.14M beats by $2.75M [2/2/2022 5:18 PM] |
25.35 |
-1.58 (-5.87%) |
26.93 |
0.0 (0.00%) |
21.08 - 49.87 |
773,239 |
350,000 |
10,638 |
|
|
27-10-2021 |
AH |
5:15 PM ET (Oct 27) |
CLB |
Core Laboratories N.V. |
1,310 |
0.18 |
0.19 |
0.16 |
Core Laboratories EPS misses by $0.01, misses on revenue [10/27/2021 5:34 PM] |
25.07 |
-1.23 (-4.68%) |
25.57 |
-0.73 (-2.78%) |
13.43 - 49.87 |
966,296 |
560,000 |
141 |
|
|
28-07-2021 |
AH |
5:15 PM ET (Jul 28) |
CLB |
Core Laboratories N.V. |
1,580 |
0.18 |
0.19 |
0.14 |
Core Laboratories EPS misses by $0.01, misses on revenue [7/28/2021 5:22 PM] |
33.46 |
-1.70 (-4.84%) |
34.14 |
-1.02 (-2.90%) |
13.43 - 49.87 |
496,620 |
410,000 |
18,776 |
|
|
21-04-2021 |
AH |
5:00 PM ET (Apr 21) |
CLB |
Core Laboratories N.V. |
1,270 |
0.15 |
0.13 |
0.31 |
Core Laboratories EPS beats by $0.02, misses on revenue [4/21/2021 5:13 PM] |
27.01 |
0.01 (0.04%) |
27.52 |
0.52 (1.93%) |
12.50 - 41.98 |
451,960 |
370,000 |
441 |
|
|
27-01-2021 |
AH |
5:15 PM ET (Jan 27) |
CLB |
Core Laboratories N.V. |
1,560 |
0.18 |
0.17 |
0.38 |
Core Laboratories EPS beats by $0.02, beats on revenue [1/27/2021 5:38 PM] |
33.05 |
0.13 (0.39%) |
32.92 |
0.0 (0.00%) |
6.68 - 37.62 |
720,825 |
515,505 |
4,230 |
|
|
21-10-2020 |
AH |
5:15 PM ET (Oct 21) |
CLB |
Core Laboratories N.V. |
660.59 |
0.16 |
0.14 |
0.50 |
Core Laboratories EPS beats by $0.01, misses on revenue [10/21/2020 5:24 PM] |
14.98 |
0.52 (3.60%) |
14.60 |
0.14 (0.97%) |
6.68 - 49.22 |
821,713 |
414,222 |
125 |
|
|
22-07-2020 |
AH |
5:05 PM ET (Jul 22) |
CLB |
Core Laboratories N.V. |
902.47 |
0.14 |
0.09 |
0.46 |
Core Laboratories EPS beats by $0.03, beats on revenue [7/22/2020 5:25 PM] |
22.84 |
0.58 (2.63%) |
23.00 |
0.74 (3.32%) |
6.68 - 55.51 |
530,417 |
773,471 |
337 |
|
|